Touria Aboussaouira
Casablanca, Morocco
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Vascular endothelial growth factor (VEGF) and Endocrine gland-VEGF (EG-VEGF) are down regulated in head and neck cancer.
Journal: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
Published: August 21, 2019
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.
Journal: Cancer biomarkers : section A of Disease markers
Published: December 12, 2017
Risk factors and poor prognostic factors of preeclampsia in Ibn Rochd University Hospital of Casablanca: about 401 preeclamptic cases.
Journal: The Pan African medical journal
Published: November 15, 2017
Descriptive epidemiology of peritoneal carcinosis of gastrointestinal origin at the Ibn Rochd University Hospital, Casablanca (2008-2010)
Journal: The Pan African medical journal
Published: July 06, 2017
Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression In Vitro and In Vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 22, 2017
Prokineticins in central and peripheral control of human reproduction.
Journal: Hormone molecular biology and clinical investigation
Published: August 20, 2015
The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.
Journal: BioMed research international
Published: February 06, 2014
Potential role of the angiogenic factor "EG-VEGF" in gestational trophoblastic diseases
Journal: Pathologie-biologie
Published: March 30, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026